Concepedia

Publication | Open Access

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

DOIFull Paper Access

176

Citations

16

References

2019

Year

Vince Biemans, Andrea E. van der Meulen‐de Jong, C. Janneke van der Woude, Mark Löwenberg, Gerard Dijkstra, Bas Oldenburg, Nanne K.H. de Boer, Sander van der Marel, Alexander Bodelier, Jeroen M. Jansen,
Journal of Crohn s and Colitis

Abstract

Ustekinumab is a relatively safe and effective treatment option for CD patients with prior failure of anti-TNF and anti-integrin therapies.

References

YearCitations

Page 1